Other top stories

The Weekly Mind Reader: Overprescribing Benztropine

September 1, 2023

5 Minute Pearls: Ketamine for Treatment Resistant Depression and Suicidal Ideation

August 31, 2023

A Protein That Zaps Cellular Energy May Underlie Chronic Fatigue

August 30, 2023

Neurology, Psychiatry Drugs Absent from Initial Medicare Price Negotiations

August 29, 2023

Neurological Symptoms Lead to Discovery of Unusual Brain-Invading Worm

August 29, 2023

How William James College Became a Champion For Diversity in Mental Health Care

August 28, 2023

Other stories

The Weekly Mind Reader: Catatonia Challenges and Solutions

August 25, 2023

TikTok's 'Undiagnosis' Trend Spreads Misleading Mental Health Advice

August 23, 2023

How Tardive Dyskinesia Impacts Patients Using Antipsychotics

August 22, 2023

Controversy Surrounds Brexpiprazole's FDA Approval, a New Alzheimer's Agitation Drug

August 21, 2023

The Weekly Mind Reader: Laughing Gas for Suicide Prevention

August 18, 2023

Point of View: Not All Borderline Personality Disorder is Alike

August 17, 2023

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure. Image of a syringe on two vials highlights aripiprazole monohydrate LAI clinical use in Bipolar I Disorder.

Subscribe to read
more articles

Subscribe